. In addition, we have observed variations in assay performances that led us to systematically investigate the effi cacy of these techniques. The goals of the current study were to: (1) identify quantitative biofi lm assay(s) that provide a reproducible, accurate measurement of biofi lm(s), and (2) compare time, effi ciency, and cost of the quantitative assays. Studies included the use of XTT reduction assay, crystal violet staining, DNA quantifi cation, qPCR, protein quantifi cation, dry cell weight measurement, and viable colony counting.
Materials and methods
Three C. albicans strains were chosen for their varied abilities to form biofi lms. The reference strain DAY185 produces extensive biofi lms with abundant extracellular matrices and variable cell morphologies [19] . The two mutant strains lack adhesions, resulting in a partial biofi lm defect for als3 Δ / Δ and a more extensive biofi lm defect in strain als1 Δ / Δ als3 Δ / Δ [8, 20 -22] . To evaluate biofi lm formation, overnight cultures grown in yeast peptone dextrose (YPD) broth [8] at 30 ° C with orbital shaking at 200 rpm were enumerated by hemocytometer. Cells were resuspended in RPMI-MOPS [7] at 10 6 cells/ml and each well of a six-well polystyrene plate was inoculated with 1 ml of this suspension. After a 1 h adhesion period, the inoculum was removed and fresh media was applied. Biofi lms were grown for 48 h at 37 ° C on an orbital shaker at 50 rpm. For comparative scanning electron microscopy (SEM), biofi lms were formed on coverslips and processed and examined as previously described [23] .
Introduction
Infections caused by Candida albicans frequently occur in hospitalized patients, where the pathogenic fungus forms biofi lms on medical devices [1 -5] . Because these infections are diffi cult to treat, extensive research has focused on understanding genetic and biochemical aspects of biofi lm development and the characteristic drug resistance phenotypes [6 -10] . In vitro plate assays have become a key tool for propagating Candida biofi lms and investigating their composition and properties. A necessary element of these experiments is the ability to accurately and reproducibly quantify the viable cells in the biofi lm. Not only does this serve as an important study endpoint, but it provides the data needed for the normalization of biochemical assays. Through such normalizing based on levels of cells in the biofi lms, accurate comparisons can be made between mutants and their parental strains, as well as among multiple clinical strains. Normalization can also minimize differences in growth rate as a factor when interpreting the assay ' s results.
Numerous techniques have been employed for the measurement of the quantity of cells in biofi lms. These procedures vary widely as to their time and cost requirements Protocols for the XTT and crystal violet assays have been described [7, 24] . For the crystal violet assay, 4% aqueous crystal violet was added for 45 min and 100 μ l aliquots were taken from each well for absorbance measurement (595 nm). Candida DNA quantifi cation was accomplished using a commercially available kit (Genomic DNA Wizard Kit -Promega) following cellular disruption by bead-beating [25] . DNA samples were also used for qPCR with ACT1 primers and probes [23] and Quantitect Probe qPCR kit (Qiagen) performed with the CFX96 Real-Time PCR Detection System (Bio-Rad). The Protein Assay Kit (Pierce) was used to determine total cellular protein after biofi lms were scraped from wells into 1 ml of ddH 2 O, sonicated for 20 min, disrupted by bead-beating, and boiled. Dry cell weight of each biofi lm was determined following disruption, collection, and then dehydrated by vacuum centrifugation. Viable burdens were determined by plating serial dilutions following biofi lm disruption, vortexing, and sonicated using a waterbath for 20 min to disperse cells [14] .
Reproducibility was estimated by the standard deviation and coeffi cient of variation among replicates. At least six biofi lms were grown for each strain and assay.
Results
The differences in biofi lm formation among the strains was observed visually and confi rmed with SEM. The reference strain DAY185 produced extensive biofi lms with abundant extracellular matrices and variable cell morphologies (Fig. 1 ). An intermediate biofi lm defect was found for the als3 Δ / Δ mutant, with few clumps of adherent hyphae. As previously described, a profound biofi lm defect was noted for als1 Δ / Δ als3 Δ / Δ mutant, with fewer adherent cells present. This was less apparent visually in the 6-well format, as als1 Δ / Δ als3 Δ / Δ more closely resembled als3 Δ / Δ , possibly due to a difference between the coverslip and 6-well growth models.
The XTT assay accurately detected the observed differences in the extent of biofi lm formation between the parent and the two biofi lm defi cient strains ( Fig. 2A) . In addition, the measurements were reproducible. However, the assay did not differentiate between the more modest differences in the biofi lms of the two mutants. Although reproducible, the crystal violet assay did not detect the anticipated differences in the biofi lms among the strains (Fig. 2B) . Total DNA quantifi cation and ACT1 qPCR failed to detect the biofi lm defects of the mutants ( Fig. 2C  and 2D ). In fact, a higher concentration of DNA was detected for the poor biofi lm forming mutants for reasons that are unclear. For the total cellular protein assay, we observed signifi cant variability in assay replicates and the measurements did not accurately refl ect the differences in the extent of biofi lms among strains (Fig. 2E) .
Although the viable counts were reproducible for an individual strain, the degree of the expected biofi lm defects of the mutants was not appreciated using this method (Fig. 2F ).
Among the assays tested, the most time consuming included the total DNA and qPCR methods ( Table 1) . The most costly technique was the qPCR. The least expensive viable option both from the standpoint of time and supplies was the XTT assay.
Discussion
There are several possible explanations for the variability observed with several of the assays. First, those that require removal of the adherent biofi lms (total DNA, qPCR, total protein, and viable burden) may create inconsistent cell collection. We have confi rmed this hypothesis by performing XTT assays on disrupted biofi lms and fi nding that up to 30% may remain in the well despite multiple washes and the appearance that the fi lms were removed (data not shown). Secondly, for several of the assays (total protein and cell weight assays) the measured values for biofi lms in the 6-well format were small relative to the limit of detection.
For the C. albicans strains tested, we found the XTT assay to be the most reproducible, accurate, and effi cient method for measurement of biofi lm extent. Measurement of viable burden was also a fairly reproducible method of quantifying biofi lm formation. 
Accuracy represents whether the data matches with the pattern seen in SEM images, as well as whether the differences between the strains was signifi cant (P < 0.05). Reproducibility is determined by the coeffi cient of variation (CV) for each set of data. ϩϩϩϩ ϭ CV <0.1, ϩϩϩ ϭ CV of 0.1-0.15, ϩϩ = CV of 0.15-0.2, ϩ ϭ CV of >0.2. Time accounts for both the total lengths of the protocols, and the amount of labor required for each, with ϩϩϩϩ representing the most time consuming protocols. Cost is based on the amount needed per 6-well plate, and presumes that researchers already have access to any large devices required. ϩϩϩϩ ϭ >$100 per plate, ϩϩϩ ϭ $20-100, ϩϩ ϭ $10-20, ϩ ϭ <$10.
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